• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of norethisterone oenanthate in humans.

作者信息

Sang G W, Fotherby K, Howard G, Elder M, Bye P G

出版信息

Contraception. 1981 Jul;24(1):15-27. doi: 10.1016/0010-7824(81)90065-2.

DOI:10.1016/0010-7824(81)90065-2
PMID:7273765
Abstract

The pharmacokinetics of a dose of 200 mg NET-OEN were studied after intramuscular injection into nine subjects. Blood levels of NET and NET-OEN increased rapidly, reaching peaks in most subjects within seven days. At all times after injection, serum levels of NET exceeded those of NET-OEN. The half-life of absorption varied from 5.4 to 22.3 days and the half-life of elimination varied from 7.5 to 22.5 days; there was a significant correlation (R = 0.78) between these two half-lives. There were significant correlations between the absorption half-lives and the peak values of NET and NET-OEN, the time to reach peak values and the time for which NET was detectable in serum. In all subjects NET was detectable in the circulation for a longer time after injection (mean value 74 days) than NET-OEN (mean value 43 days). The time for which the two steroids were detectable in the circulation showed a significant correlation with the elimination half-lives but there was no correlation with the peak values attained, the time taken to reach peak values and bioavailability. There was a two-fold variation between the subjects in the bioavailability of NET, less than 5% of the bioavailable NET was released after day 60.

摘要

相似文献

1
Pharmacokinetics of norethisterone oenanthate in humans.
Contraception. 1981 Jul;24(1):15-27. doi: 10.1016/0010-7824(81)90065-2.
2
The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.注射用庚酸炔诺酮对泰国女性卵巢激素的影响。
Contraception. 1980 Mar;21(3):299-309. doi: 10.1016/0010-7824(80)90008-6.
3
Pharmacokinetics of norethisterone in humans.
Contraception. 1987 May;35(5):465-75. doi: 10.1016/0010-7824(87)90083-7.
4
Pharmacokinetics of different doses of norethisterone oenanthate.不同剂量庚酸炔诺酮的药代动力学
Contraception. 1984 Apr;29(4):325-33. doi: 10.1016/0010-7824(84)90066-0.
5
Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
Acta Obstet Gynecol Scand. 1983;62(1):71-6. doi: 10.3109/00016348309155763.
6
Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
Steroids. 1989 Jun;53(6):751-61. doi: 10.1016/0039-128x(89)90065-2.
7
Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).两种避孕制剂的I期临床试验。庚酸炔诺酮(NEN)和醋酸炔诺酮(NET)。
Contraception. 1981 Feb;23(2):141-55. doi: 10.1016/0010-7824(81)90100-1.
8
A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.炔诺酮(NET)的放射免疫分析:摄入含NET的口服避孕药类固醇后血清NET浓度的测定。
Contraception. 1978 Dec;18(6):615-33. doi: 10.1016/0010-7824(78)90046-x.
9
Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
Fertil Steril. 1996 Dec;66(6):954-61. doi: 10.1016/s0015-0282(16)58689-0.
10
Variability of pharmacokinetic parameters for contraceptive steroids.
J Steroid Biochem. 1983 Jul;19(1C):817-20. doi: 10.1016/0022-4731(83)90017-1.

引用本文的文献

1
Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry.开发并验证了一种通过液相色谱-串联质谱法测定血浆中长效激素避孕药的多重分析方法。
J Pharm Biomed Anal. 2023 May 10;228:115321. doi: 10.1016/j.jpba.2023.115321. Epub 2023 Mar 5.
2
Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.避孕用孕激素的药代动力学、代谢和血清浓度。
Pharmacol Ther. 2021 Jun;222:107789. doi: 10.1016/j.pharmthera.2020.107789. Epub 2020 Dec 13.
3
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.
避孕药醋酸甲羟孕酮与诺孕酯不同,它能在生理相关浓度下直接增加人体宫颈组织中 R5 HIV-1 的感染。
Sci Rep. 2019 Mar 13;9(1):4334. doi: 10.1038/s41598-019-40756-7.
4
Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.醋酸甲羟孕酮与炔诺酮不同,通过涉及糖皮质激素受体、增加 CD4/CD8 比值和 CCR5 水平的机制,增加了人类外周血单核细胞和指示细胞系中 HIV-1 的复制。
PLoS One. 2018 Apr 26;13(4):e0196043. doi: 10.1371/journal.pone.0196043. eCollection 2018.
5
Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.激素避孕与 HIV-1 感染:生物学机制。
Endocr Rev. 2018 Feb 1;39(1):36-78. doi: 10.1210/er.2017-00103.
6
Long acting contraceptives. Present status.长效避孕药。现状。
Drugs. 1983 Jun;25(6):570-609. doi: 10.2165/00003495-198325060-00003.
7
Facts about injectable contraceptives: memorandum from a WHO meeting.关于注射用避孕药的事实:世界卫生组织会议备忘录
Bull World Health Organ. 1982;60(2):199-210.